Work Experience Party Branch Secretary of the Ophthalmology Department, Deputy Director of Scientific Research. Education: 2001.09 – 2005.07 Peking University, Ophthalmology, Ph.D., Supervisor: Wang Wei 1996.03 – 1998.07 Beijing Medical University, Ophthalmology, Master's Degree, Supervisor: Zhu Xiu'an 1991.09 – 1996.03 Beijing Medical University, Clinical Medicine, Bachelor's Degree Work Experience: Member of the Party Committee of Peking University Third Hospital; Member of the Teaching Management Committee of Peking University Third Hospital; Member of the Infection Management Committee of Peking University Third Hospital; Party Branch Secretary of the Ophthalmology Department of Peking University Third Hospital; Teaching Secretary of the Ophthalmology Department of Peking University Third Hospital; Medical Assistant to the Director of the Ophthalmology Department of Peking University Third Hospital Research Activities (1) Beijing Municipal Natural Science Foundation, General Project No. 7202229, "Molecular mechanism study of congenital cataract caused by MYH9 gene mutations and their correlation with the F-actin protein network," 2020.01–2022.12, 200,000 RMB, ongoing, Principal Investigator; (2) National Major Science and Technology Project, No. 2018ZX0101004, "Research on key safeguard technologies for the prevention and control of important infectious diseases in East Africa, Central Asia, and Southeast Asia—Research on safeguard technologies for the prevention and control of important infectious diseases in Southeast Asia," 2018.01–2020.12, 743,000 RMB, ongoing, Participant; (3) Peking University Medicine Seed Fund for Interdisciplinary Research, 2021.1–2021.12; "Study on the efficacy, safety, and mechanism of transcutaneous electrical acupoint stimulation around the eyes for delaying myopia progression in children," ongoing, Principal Investigator; (4) Capital Health Development Research Special Project, No. 2018-2-4093, "Study on the efficacy and safety of bianstone moxibustion infrared dry eye therapeutic device in the treatment of meibomian gland dysfunction," 2018.01–2020.12, 400,000 RMB, ongoing, Principal Investigator; (5) Capital Clinical Characteristic Application Research Project, No. Z141107002514042, "Application of corneal confocal laser microscopy in the diagnosis and treatment of external ocular malignant tumors," 2014.01–2016.12, 150,000 RMB, completed, Principal Investigator; Awards and Honors (1) Recipient of the first "Peking University Clinical Medical Award"; (2) As Chief Scientist and Principal Project Lead, directed the multicenter clinical validation of the novel corneal graft "Acellular Dermal Matrix (ADM)," which was nominated for the 2017 National Science and Technology Progress Award.